Prodigy update - February 2012
Prodigy has been updated in February 2012 for the following clinical areas:
- Attention deficit hyperactivity disorder
- Bipolar disorder
- Breastfeeding problems
- Contraception - assessment
- Contraception - emergency
- Dyspepsia - proven GORD
- Dyspepsia - proven non-ulcer
- Dyspepsia - unidentified cause
- Epilepsy
- Headache - medication overuse
- Lipid modification - CVD prevention
- Migraine
- MI - secondary prevention
- Palliative cancer care - nausea & vomiting
- Parkinson's disease
- Renal colic - acute
- Schizophrenia
- Stroke and TIA
Some of these topics have had minor updates applied since last month including new drug safety information. Quetiapine has been rarely associated with diabetic ketoacidosis and domperidone has been associated with an increased risk of serious ventricular arrhythmias.
Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.
| « PPIs and risk of postmenopausal hip fracture | Apidra supply restored » |
